These cytokines influence depression-related pathophysiology by activating innate immune signaling pathways, including TLR4, NF-κB, MAPK, and the NLRP3 inflammasome, while also reshaping tryptophan-kynurenine metabolism through IDO1 and TDO2. The gene discussed is TLR4; the disease is depressive symptom measurement.